| Literature DB >> 32335738 |
Julia Risso Parisi1, Kelly Rossetti Fernandes2, Matheus de Almeida Cruz3, Ingrid Regina Avanzi3, Alan de França Santana3, Giovanna Caroline Aparecida do Vale3, Ana Laura Martins de Andrade2, Cíntia Pereira de Góes3, Carlos Alberto Fortulan4, Eliandra de Sousa Trichês5, Renata Neves Granito3, Ana Claudia Muniz Rennó3.
Abstract
One of the most promising strategies to improve the biological performance of bone grafts is the combination of different biomaterials. In this context, the aim of this study was to evaluate the effects of the incorporation of marine spongin (SPG) into Hydroxyapatite (HA) for bone tissue engineering proposals. The hypothesis of the current study is that SPG into HA would improve the biocompatibility of material and would have a positive stimulus into bone formation. Thus, HA and HA/SPG materials were produced and scanning electron microscopy (SEM) analysis was performed to characterize the samples. Also, in order to evaluate the in vivo tissue response, samples were implanted into a tibial bone defect in rats. Histopathological, immunohistochemistry, and biomechanical analyses were performed after 2 and 6 weeks of implantation to investigate the effects of the material on bone repair. The histological analysis demonstrated that composite presented an accelerated material degradation and enhanced newly bone formation. Additionally, histomorphometry analysis showed higher values of %BV/TV and N.Ob/T.Ar for HA/SPG. Runx-2 immunolabeling was higher for the composite group and no difference was found for VEGF. Moreover, the biomechanical analysis demonstrated similar values for all groups. These results indicated the potential of SPG to be used as an additive to HA to improve the biological performance for bone regeneration applications. However, further long-term studies should be carried out to provide additional information regarding the material degradation and bone regeneration.Entities:
Keywords: Collagen; Marine biotechnology; Marine sponges; Spongin
Mesh:
Substances:
Year: 2020 PMID: 32335738 DOI: 10.1007/s10126-020-09955-6
Source DB: PubMed Journal: Mar Biotechnol (NY) ISSN: 1436-2228 Impact factor: 3.619